CN Patent

CN111801324B — 甲状腺激素受体激动剂及其用途

Assigned to Tibet Haisike Pharmaceutical Co ltd · Expires 2021-10-22 · 5y expired

What this patent protects

本申请描述了用于治疗与甲状腺激素受体活性相关的病症、疾病或障碍的方法和组合物。本申请公开的方法和组合物包括使用至少一种甲状腺激素受体激动剂。

USPTO Abstract

本申请描述了用于治疗与甲状腺激素受体活性相关的病症、疾病或障碍的方法和组合物。本申请公开的方法和组合物包括使用至少一种甲状腺激素受体激动剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111801324B
Jurisdiction
CN
Classification
—
Expires
2021-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Tibet Haisike Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.